Medtronic plc added a second U.S. FDA pulsed field ablation (PFA) device approval to its scorecard with the agency’s ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Analyst Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price ...

Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.

Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again.

This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...

This content was published on Oct 24, 2024 On Thursday, the Swiss Federal Railways presented its first fully renovated InterCity tilting train (ICN). Read more: Swiss railways presents first fully ...

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.